IL150260A0 - Propionic acid derivatives and their use in the treatment of diabetes and obesity - Google Patents
Propionic acid derivatives and their use in the treatment of diabetes and obesityInfo
- Publication number
- IL150260A0 IL150260A0 IL15026001A IL15026001A IL150260A0 IL 150260 A0 IL150260 A0 IL 150260A0 IL 15026001 A IL15026001 A IL 15026001A IL 15026001 A IL15026001 A IL 15026001A IL 150260 A0 IL150260 A0 IL 150260A0
- Authority
- IL
- Israel
- Prior art keywords
- obesity
- diabetes
- treatment
- propionic acid
- acid derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
- C07C69/708—Ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
- C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/72—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings and other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/734—Ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/40—Radicals substituted by oxygen atoms
- C07D307/42—Singly bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/80—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/54—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
- C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
- C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
- C07C2603/18—Fluorenes; Hydrogenated fluorenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
- C07C2603/26—Phenanthrenes; Hydrogenated phenanthrenes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Quinoline Compounds (AREA)
- Furan Compounds (AREA)
- Pyridine Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200000136 | 2000-01-28 | ||
DKPA200001071 | 2000-07-07 | ||
DKPA200001594 | 2000-10-25 | ||
PCT/DK2001/000058 WO2001055085A1 (fr) | 2000-01-28 | 2001-01-26 | Derives de l'acide propionique et leur utilisation dans le traitement du diabete et de l'obesite |
Publications (1)
Publication Number | Publication Date |
---|---|
IL150260A0 true IL150260A0 (en) | 2002-12-01 |
Family
ID=27222336
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15026001A IL150260A0 (en) | 2000-01-28 | 2001-01-26 | Propionic acid derivatives and their use in the treatment of diabetes and obesity |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1254101A1 (fr) |
JP (1) | JP2003520838A (fr) |
KR (1) | KR20020070508A (fr) |
CN (1) | CN1396903A (fr) |
AU (1) | AU2831901A (fr) |
BR (1) | BR0107901A (fr) |
CA (1) | CA2395298A1 (fr) |
HU (1) | HUP0204574A3 (fr) |
IL (1) | IL150260A0 (fr) |
MX (1) | MXPA02007286A (fr) |
NO (1) | NO20023566L (fr) |
PL (1) | PL357010A1 (fr) |
WO (1) | WO2001055085A1 (fr) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100506870C (zh) | 2001-03-08 | 2009-07-01 | 宾夕法尼亚州大学理事会 | 作为抗感染药的表面两亲聚合物 |
TWI311133B (en) | 2001-04-20 | 2009-06-21 | Eisai R&D Man Co Ltd | Carboxylic acid derivativeand the salt thereof |
RU2004105956A (ru) * | 2001-07-30 | 2005-03-27 | Ново Нордиск А/С (DK) | Новые производные винилкарбоновых кислот и их применение в качестве антидиабетических средств и т.п. |
US6869967B2 (en) | 2001-07-30 | 2005-03-22 | Novo Nordisk A/S | Peroxisome proliferator-activated receptor (PPAR) active vinyl carboxylic acid derivatives |
US7067530B2 (en) | 2001-07-30 | 2006-06-27 | Novo Nordisk A/S | Compounds, their preparation and use |
WO2003016265A1 (fr) | 2001-08-17 | 2003-02-27 | Eisai Co., Ltd. | Compose cyclique et agoniste du recepteur ppar |
WO2003037316A1 (fr) | 2001-10-11 | 2003-05-08 | Kaneka Corporation | Ligands de recepteurs actives par le proliferateur de peroxisome et procede de fabrication correspondant |
EP1438283A1 (fr) * | 2001-10-17 | 2004-07-21 | Novo Nordisk A/S | Derives d'acide dicarboxylique, leur preparation et leur utilisation therapeutique |
US7220877B2 (en) | 2001-10-17 | 2007-05-22 | Novo Nordisk A/S | Compounds, their preparation and use |
RU2005109555A (ru) | 2002-09-05 | 2005-11-10 | Ново Нордиск А/С (DK) | Новые производные винилкарбоновой кислоты и их терапевтическое применение |
AU2003273784A1 (en) | 2002-10-28 | 2004-05-13 | Novo Nordisk A/S | Novel compounds useful in treating ppar mediated diseases |
US20050080115A1 (en) | 2002-10-28 | 2005-04-14 | Lone Jeppesen | Novel compounds, their preparation and use |
EP2385032A1 (fr) | 2002-11-08 | 2011-11-09 | Takeda Pharmaceutical Company Limited | Régulateur de fonction de récepteur GPR40 |
US7268157B2 (en) * | 2002-11-26 | 2007-09-11 | Shenzhen Chipscreen Biosciences, Ltd. | Substituted arylalcanoic acid derivatives as PPAR pan agonists with potent antihyperglycemic and antihyperlipidemic activity |
US7192970B2 (en) | 2002-11-26 | 2007-03-20 | Chipscreen Biosciences, Ltd. | Noncyclic 1,3-dicarbonyl compounds as dual PPAR agonists with potent antihyperglycemic and antihyperlipidemic activity |
US9241917B2 (en) | 2003-03-17 | 2016-01-26 | The Trustees Of The University Of Pennsylvania | Facially amphiphilic polymers and oligomers and uses thereof |
ITRM20030305A1 (it) * | 2003-06-20 | 2004-12-21 | Sigma Tau Ind Farmaceuti | Preparazione di nuovi derivati di acidi fenil o fenossialchil mono e dicarbossilici utili nel trattamento dell'iperglicemia e dell'ipertrigliceridemia tipiche del diabete del tipo ii. |
JP4922615B2 (ja) | 2003-11-26 | 2012-04-25 | 武田薬品工業株式会社 | 受容体機能調節剤 |
AU2004309271A1 (en) | 2003-12-25 | 2005-07-14 | Takeda Pharmaceutical Company Limited | 3-(4-benzyloxyphenyl)propanoic acid derivatives |
US7585880B2 (en) | 2003-12-26 | 2009-09-08 | Takeda Pharmaceutical Company Limited | Phenylpropanoic acid derivatives |
WO2005072246A2 (fr) * | 2004-01-23 | 2005-08-11 | The Trustees Of The University Of Pennsylvania | Polymeres et oligomeres de polyaryle et de polyarylalkynyle amphiphiles au niveau facial |
GB0403148D0 (en) * | 2004-02-12 | 2004-03-17 | Smithkline Beecham Corp | Chemical compounds |
ATE515494T1 (de) | 2004-05-05 | 2011-07-15 | High Point Pharmaceuticals Llc | Neue verbindungen, deren herstellung und verwendung |
RU2006144121A (ru) * | 2004-05-14 | 2008-06-20 | Айрм Ллк (Us) | Соединения и композиции в качестве модуляторов ppar рецепторов, активируемых пролифератором пероксисом |
CN1968932A (zh) | 2004-06-18 | 2007-05-23 | 惠氏公司 | 制备6-烷基-5-芳基磺酰基-二氢菲啶的方法 |
WO2007071766A2 (fr) | 2005-12-22 | 2007-06-28 | Transtech Pharma | Nouveaux composes, leur preparation et leur utilisation |
KR100788454B1 (ko) * | 2006-06-15 | 2007-12-24 | 대원제약주식회사 | 속효성이 증진된 나테글리니드를 유효성분으로 함유하는약제학적 조성물 |
KR101497577B1 (ko) * | 2012-07-31 | 2015-03-02 | 서울대학교산학협력단 | 2-에톡시프로피온산 유도체 또는 이의 약학적으로 허용가능한 염을 유효성분으로 함유하는 일주기 연관성 질환의 예방 또는 치료용 약학적 조성물 |
BR112023001048A2 (pt) | 2020-07-22 | 2023-04-04 | Reneo Pharmaceuticals Inc | Agonista de ppar-delta cristalino |
CN114349723B (zh) * | 2021-12-23 | 2024-02-02 | 中山大学 | 多烯炔类化合物及其制备方法和应用 |
WO2023147309A1 (fr) | 2022-01-25 | 2023-08-03 | Reneo Pharmaceuticals, Inc. | Utilisation d'agonistes ppar-delta dans le traitement d'une maladie |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2200248T3 (es) * | 1997-09-19 | 2004-03-01 | Ssp Co., Ltd. | Derivados de acudi fenilpropionico sustituido en alfa y medicamento que los contienen. |
EP1124807A1 (fr) * | 1997-10-27 | 2001-08-22 | Dr. Reddy's Research Foundation | Nouvelles compositions heterocycliques et leur utilisation en medecine; procedes de leur fabrication et compositions pharmaceutiques les contenant |
WO1999019313A1 (fr) * | 1997-10-27 | 1999-04-22 | Dr. Reddy's Research Foundation | Nouveaux composes tricycliques et leur utilisation en medecine, procede de preparation de ces derniers et compositions pharmaceutiques les contenant |
WO1999038850A1 (fr) * | 1998-01-29 | 1999-08-05 | Dr. Reddy's Research Foundation | Nouveaux acides alcanoiques et leur utilisation en medecine, leur procede de preparation et compositions pharmaceutiques les contenant |
WO1999008501A2 (fr) * | 1998-04-23 | 1999-02-25 | Dr. Reddy's Research Foundation | Nouveaux composes heterocycliques, leur utilisation en medecine, leur procede de preparation et compositions pharmaceutiques les contenant |
JP2002507543A (ja) * | 1998-05-27 | 2002-03-12 | ドクター・レディーズ・リサーチ・ファウンデーション | 二環系化合物、その製造方法およびそれらを含有する薬学的組成物 |
WO2000063153A1 (fr) * | 1999-04-20 | 2000-10-26 | Novo Nordisk A/S | Nouveaux composes, preparation et utilisation de ces derniers |
-
2001
- 2001-01-26 HU HU0204574A patent/HUP0204574A3/hu unknown
- 2001-01-26 JP JP2001555028A patent/JP2003520838A/ja active Pending
- 2001-01-26 MX MXPA02007286A patent/MXPA02007286A/es unknown
- 2001-01-26 IL IL15026001A patent/IL150260A0/xx unknown
- 2001-01-26 PL PL01357010A patent/PL357010A1/xx not_active Application Discontinuation
- 2001-01-26 AU AU28319/01A patent/AU2831901A/en not_active Abandoned
- 2001-01-26 CN CN01804241A patent/CN1396903A/zh active Pending
- 2001-01-26 KR KR1020027009463A patent/KR20020070508A/ko not_active Application Discontinuation
- 2001-01-26 CA CA002395298A patent/CA2395298A1/fr not_active Abandoned
- 2001-01-26 BR BR0107901-8A patent/BR0107901A/pt not_active IP Right Cessation
- 2001-01-26 WO PCT/DK2001/000058 patent/WO2001055085A1/fr not_active Application Discontinuation
- 2001-01-26 EP EP01946844A patent/EP1254101A1/fr not_active Withdrawn
-
2002
- 2002-07-26 NO NO20023566A patent/NO20023566L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR20020070508A (ko) | 2002-09-09 |
CN1396903A (zh) | 2003-02-12 |
HUP0204574A2 (en) | 2003-05-28 |
MXPA02007286A (es) | 2002-11-29 |
PL357010A1 (en) | 2004-07-12 |
HUP0204574A3 (en) | 2003-08-28 |
CA2395298A1 (fr) | 2001-08-02 |
NO20023566L (no) | 2002-09-25 |
EP1254101A1 (fr) | 2002-11-06 |
WO2001055085A1 (fr) | 2001-08-02 |
BR0107901A (pt) | 2002-11-05 |
AU2831901A (en) | 2001-08-07 |
JP2003520838A (ja) | 2003-07-08 |
NO20023566D0 (no) | 2002-07-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL150260A0 (en) | Propionic acid derivatives and their use in the treatment of diabetes and obesity | |
HUP0203367A3 (en) | Benzylidine-thiazolidinediones and analogues and their use in the treatment of diabetes | |
AU2001293553A1 (en) | Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment | |
IL160917A0 (en) | Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions | |
HK1062914A1 (en) | Glucopyranosyloxypyrazole derivatives and use thereof in medicines | |
AU2002221881A1 (en) | Carboxylic acid amide derivatives and their use in the treatment of thromboembolic diseases and tumours | |
EP1515725A4 (fr) | Utilisation de derives de cyclothiocarbamate pour le traitement de pathologies d'origine hormonale | |
IL165395A0 (en) | Use of thio-oxubdile derivatives in treatment of hormone-related conditions | |
IL150259A0 (en) | Alkylnyl-substituted propionic acid derivatives and their use against diabetes and obesity | |
AP2002002393A0 (en) | Naphthoquinone derivatives and their use in the treatment and control of tuberculosis | |
AU2003286285A1 (en) | Use of fgf-18 in the diagnosis and treatment of memory disorders | |
IL155125A0 (en) | Propionic acid derivatives with ppar-alpha activating properties | |
AU2003244455A1 (en) | Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases | |
PL378197A1 (pl) | Pochodne kwasów indenokarboksylowych oraz ich zastosowanie do leczenia i zapobiegania cukrzycy i dyslipidemii | |
AU2001296477A1 (en) | Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas | |
NO20043614L (no) | 2`-halogen-3`,5`-dialkoksyfen-1`-yl-imino-2-imidazolid in-derivater og anvendelse derav for behandling av urin-inkontinens | |
ZA200204799B (en) | Propionic acid derivatives and their use in the treatment of diabetes and obesity. | |
AU2003270350A1 (en) | Isoxazoles and their use in the treatment of ischemic diseases | |
AU2001254825A1 (en) | Butenoic acids derivatives and their use in the treatment of rhinitis | |
AU6613100A (en) | Use of stanniocalcin 2 in the treatment of type ii diabetes and complications thereof | |
AU6330300A (en) | Use of interleukin-6 in treatment of obesity and/or obesity associated disorders | |
AU2003244437A1 (en) | Quinoxalinones and their use especially in the treatment of cardiovascular diseases | |
ZA200204800B (en) | Alkynylsubstituted propionic acid derivatives and their use against diabetes and obesity. | |
AU2001233934A1 (en) | Ccr2-64i, polymorphic variant of the human ccrs receptor and its use in the diagnostic and treatment of atherosclerosis | |
AU2002345165A1 (en) | The use of rhein and derivatives thereof in pain treatment |